info@scandibio.com
Toggle menu
About Us
Our Science
Scientific rationale
The Team
Clinical Studies
Phase I/II: SERINE
Phase I: METABOLIC COFACTORS
Phase II: NAFLD
Phase II: AD/PD
Phase II: COVID-19
Phase III: COVID-19
Publications
News
Contact
Advisory Board
ScandiBio Therapeutics
→
Advisory Board
Chairman
Professor Mathias Uhlen
Board Member
Professor Adil Mardinoglu
Board Member
Professor Jan Boren
